<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">2554</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url">http://dx.doi.org/10.31782/IJCRR.2019.1122</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>An Innovative Quinone (Pyrroloquinoline Quinone) and its Antiproliferative Effects&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>lores-Encarnacion</surname><given-names>F</given-names></name></contrib><contrib contrib-type="author"><name><surname>M.</surname><given-names/></name></contrib><contrib contrib-type="author"><name><surname>I.</surname><given-names>Cabrera-Aguilar</given-names></name></contrib><contrib contrib-type="author"><name><surname>G.R.</surname><given-names>Aguilar-Gutierrez</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cabrera-Maldonado</surname><given-names/></name></contrib><contrib contrib-type="author"><name><surname>C.</surname><given-names/></name></contrib></contrib-group><pub-date pub-type="ppub"><day>22</day><month>01</month><year>2019</year></pub-date><volume>)</volume><issue/><fpage>7</fpage><lpage>10</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>The pyrroloquinoline quinine is a cofactor discovered in bacteria. It is associated with various bacterial soluble and membrane enzymes that directly oxidize sugars, alcohols, aldehydes. In higher organisms, it has been reported that pyrroloquinoline quinine acts as a potent free radical scavenger and it seems to intervene in different processes causing remarkable benefits. One of the most important effects is that pyrroloquinoline quinine induced apoptosis in different cancer cell lines. It is interesting to observe the role of pyrroloquinoline quinine as pro-apoptotic agent. This review shows the most relevant aspects of this cofactor and its antiproliferative effects.&#13;
</p></abstract><kwd-group><kwd>Pyrroloquinoline quinone</kwd><kwd> PQQ</kwd><kwd> Cofactor</kwd><kwd> Effect</kwd><kwd> Antiproliferative</kwd></kwd-group></article-meta></front></article>
